Page 1 of Clinical Trials for Drug ethinyl estradiol norelgestromin transdermal contraceptive, 20 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
A Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Who Take Oral Contraceptives for Birth Control
Last Updated: May 18, 2011
Condition(s): Contraception; Female Contraception
2
Completed
A Study to Evaluate the Exposure of Norelgestromin and Ethinyl Estradiol From Commercial Lots of EVRA (a Transdermal Contraceptive Patch Manufactured by LOHMANN Therapie-Systeme) and CILEST (an Oral Contraceptive)
Last Updated: June 6, 2011
Condition(s): Contraception; Female Contraception
3
Completed
A Comparative Pharmacokinetic Study of ORTHO EVRA (a Transdermal Contraceptive Patch) and CILEST (an Oral Contraceptive) in Healthy Female Volunteers
Last Updated: June 6, 2011
Condition(s): Contraception; Female Contraception
4
Completed
A Study to Evaluate the Hormone Exposure From Multiple Commercial Lots of ORTHO EVRA (a Transdermal Contraceptive Patch)
Last Updated: June 9, 2011
Condition(s): Contraception; Female Contraception
5
Completed
Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women
Last Updated: May 17, 2012
Condition(s): HIV Infections; Pregnancy
6
Completed
Bioequivalence Study of Patches With Different Equilibration Profiles
Last Updated: June 6, 2011
Condition(s): Female Contraception
7
Completed
Evaluation of Women's Experience With EVRA (Norelgestromin + Ethinyl Estradiol) Transdermal Contraceptive Patch Compared With Previous Methods of Contraception.
Last Updated: November 15, 2010
Condition(s): Contraception; Female Contraception
8
Completed
Bioequivalence Study of Patches With Different Release Profiles
Last Updated: June 6, 2011
Condition(s): Female Contraception
9
Completed
An Open-label, Multicentre Study on Preference and Satisfaction of Canadian Women for the Transdermal Contraceptive Patch vs. Previous Primary Contraceptive Method
Last Updated: March 25, 2010
Condition(s): Female Contraception
10
Completed
PARIS or PAtch RIng Study: A Trial to Evaluate NuvaRing Versus OrthoEvra
Last Updated: October 20, 2008
Condition(s): Contraception
11
Completed
The Effect of an Adhesive Overlay on the Delivery of Contraceptive Hormones From ORTHO EVRA® in Healthy Women
Last Updated: February 15, 2012
Condition(s): Healthy Volunteers
12
Completed
The Effect of Hormonal Contraceptives on Androgens and Glucose Metabolism
Last Updated: September 6, 2011
Condition(s): Contraception
13
Completed
Birth Control Patch Study
Last Updated: April 10, 2012
Condition(s): Contraception
14
Active, not recruiting
Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart Attacks
Last Updated: May 18, 2011
Condition(s): Contraception; Female Contraception
15
Completed
A Study of Efficacy and Safety With the Transdermal Contraceptive System.
Last Updated: November 15, 2010
Condition(s): Contraception; Female Contraception
16
Completed
A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Triphasil.
Last Updated: June 6, 2011
Condition(s): Contraception; Female Contraception
17
Completed
A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Mercilon.
Last Updated: June 6, 2011
Condition(s): Contraception
18
Completed
Relative Risks for Non-Fatal Venous Thromboembolism, Ischemic Stroke and Myocardial Infarction in Users of ORTHO EVRA(Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared to Levonorgestrel-Containing Oral Contraceptives.
Last Updated: October 11, 2007
Condition(s): Female Contraception; Contraception; Fertility Control
19
Completed
Birth Control Pill vs Birth Control Patch Study
Last Updated: November 6, 2007
Condition(s): Venous Thrombosis
20
Withdrawn
Pharmacokinetics and Safety of Transdermal Megestrol Acetate
Last Updated: February 3, 2009
Condition(s): Cachexia

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+ethinyl+estradiol+norelgestromin+transdermal+contraceptive

Page 1 of Clinical Trials for Drug ethinyl estradiol norelgestromin transdermal contraceptive, 20 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About